Portfolio of Specialty Pharmaceutical Stocks

Here are 4 specialty pharmaceutical companies.


4 Specialty Pharmaceutical Stocks

Name and Returns

Symbol

Recent Prices

AlkermesALKS
BioMarin PharmaceuticalBMRN
Endo InternationalENDP
MallinckrodtMNK
Price charts from Alpha Vantage as of most recent close.


Portfolio Values


To inspect the performance of the Specialty Pharmaceutical Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 3 stocks included in the portfolio computations are: ALKS, BMRN and ENDP. The current value of the portfolio assumes that $3,333.33 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. MNK was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $3,955. The percent return is -60.45%. The annualized return is -16.93%.





Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks

Portfolio of Generic Drug Stocks